Marie E. Laughlin

Pharmacological Induction of 5<i>α</i>-Reductase Deficiency in the Rat: Separation of Testosterone-Mediated and 5<i>α</i>-Dihydrotestosterone-Mediated Effects*

Thomas R. Blohm, Marie E. Laughlin, Harvey D. Benson et al. · Endocrinology · 1986 · 53 citations

Inhibition of testosterone 5α-reductase by a proposed enzyme-activated, active site-directed inhibitor

Thomas R. Blohm, Brian W. Metcalf, Marie E. Laughlin et al. · Biochemical and Biophysical Research Communications · 1980 · 48 citations

Molecular Pharmacology, Biochemistry, Endocrine Mechanism +7

17β-(Cyclopropylamino)-androst-5-en-3β-ol, a selective mechanism-based inhibitor of cytochrome P45017α (steroid 17α-hydroxylase/C17–20 lyase)

Michael R. Angelastro, Marie E. Laughlin, Gerald L. Schatzman et al. · Biochemical and Biophysical Research Communications · 1989 · 46 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +11

Inhibition of steroid C17(20) lyase with C-17-heteroaryl steroids

Joseph P. Burkhart, Cynthia A. Gates, Marie E. Laughlin et al. · Bioorganic & Medicinal Chemistry · 1996 · 43 citations

Biochemistry, Secondary Metabolite, Steroid C17 +2

Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat

Blake Lee Neubauer, Kevin L. Best, James A. Clemens et al. · The Prostate · 1993 · 34 citations